Cargando…

Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression

Genome-wide association studies have shown that genetic variants at 2q33.1 are strongly associated with schizophrenia. However, potential causal variants in this locus and their roles in schizophrenia remain unknown. Here, we identified two functional variants (rs796364 and rs281759) that disrupt CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shiwu, Li, Jiao, Liu, Jiewei, Wang, Junyang, Li, Xiaoyan, Huo, Yongxia, Li, Yifan, Liu, Yixing, Li, Ming, Xiao, Xiao, Luo, Xiong-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014752/
https://www.ncbi.nlm.nih.gov/pubmed/34581804
http://dx.doi.org/10.1093/brain/awab357
_version_ 1784688247900733440
author Li, Shiwu
Li, Jiao
Liu, Jiewei
Wang, Junyang
Li, Xiaoyan
Huo, Yongxia
Li, Yifan
Liu, Yixing
Li, Ming
Xiao, Xiao
Luo, Xiong-Jian
author_facet Li, Shiwu
Li, Jiao
Liu, Jiewei
Wang, Junyang
Li, Xiaoyan
Huo, Yongxia
Li, Yifan
Liu, Yixing
Li, Ming
Xiao, Xiao
Luo, Xiong-Jian
author_sort Li, Shiwu
collection PubMed
description Genome-wide association studies have shown that genetic variants at 2q33.1 are strongly associated with schizophrenia. However, potential causal variants in this locus and their roles in schizophrenia remain unknown. Here, we identified two functional variants (rs796364 and rs281759) that disrupt CTCF, RAD21 and FOXP2 binding at 2q33.1. We systematically investigated the regulatory mechanisms of these two variants with serial experiments, including reporter gene assays and electrophoretic mobility shift assay. Intriguingly, these two single nucleotide polymorphisms physically interacted with TYW5 and showed the most significant associations with TYW5 expression in human brain. Consistently, CRISPR-Cas9-mediated genome editing confirmed the regulatory effect of the two single nucleotide polymorphisms on TYW5 expression. Additionally, expression analysis indicated that TYW5 was significantly upregulated in brains of schizophrenia cases compared with controls, suggesting that rs796364 and rs281759 might confer schizophrenia risk by modulating TYW5 expression. We over-expressed TYW5 in mouse neural stem cells and rat primary neurons to mimic its upregulation in schizophrenia and found significant alterations in the proliferation and differentiation of neural stem cells, as well as dendritic spine density following TYW5 overexpression, indicating its important roles in neurodevelopment and spine morphogenesis. Furthermore, we independently confirmed the association between rs796364 and schizophrenia in a Chinese cohort of 8202 subjects. Finally, transcriptome analysis revealed that TYW5 affected schizophrenia-associated pathways. These lines of evidence consistently revealed that rs796364 and rs281759 might contribute to schizophrenia risk by regulating the expression of TYW5, a gene whose expression dysregulation affects two important schizophrenia pathophysiological processes (i.e. neurodevelopment and dendritic spine formation).
format Online
Article
Text
id pubmed-9014752
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90147522022-04-18 Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression Li, Shiwu Li, Jiao Liu, Jiewei Wang, Junyang Li, Xiaoyan Huo, Yongxia Li, Yifan Liu, Yixing Li, Ming Xiao, Xiao Luo, Xiong-Jian Brain Original Article Genome-wide association studies have shown that genetic variants at 2q33.1 are strongly associated with schizophrenia. However, potential causal variants in this locus and their roles in schizophrenia remain unknown. Here, we identified two functional variants (rs796364 and rs281759) that disrupt CTCF, RAD21 and FOXP2 binding at 2q33.1. We systematically investigated the regulatory mechanisms of these two variants with serial experiments, including reporter gene assays and electrophoretic mobility shift assay. Intriguingly, these two single nucleotide polymorphisms physically interacted with TYW5 and showed the most significant associations with TYW5 expression in human brain. Consistently, CRISPR-Cas9-mediated genome editing confirmed the regulatory effect of the two single nucleotide polymorphisms on TYW5 expression. Additionally, expression analysis indicated that TYW5 was significantly upregulated in brains of schizophrenia cases compared with controls, suggesting that rs796364 and rs281759 might confer schizophrenia risk by modulating TYW5 expression. We over-expressed TYW5 in mouse neural stem cells and rat primary neurons to mimic its upregulation in schizophrenia and found significant alterations in the proliferation and differentiation of neural stem cells, as well as dendritic spine density following TYW5 overexpression, indicating its important roles in neurodevelopment and spine morphogenesis. Furthermore, we independently confirmed the association between rs796364 and schizophrenia in a Chinese cohort of 8202 subjects. Finally, transcriptome analysis revealed that TYW5 affected schizophrenia-associated pathways. These lines of evidence consistently revealed that rs796364 and rs281759 might contribute to schizophrenia risk by regulating the expression of TYW5, a gene whose expression dysregulation affects two important schizophrenia pathophysiological processes (i.e. neurodevelopment and dendritic spine formation). Oxford University Press 2021-09-28 /pmc/articles/PMC9014752/ /pubmed/34581804 http://dx.doi.org/10.1093/brain/awab357 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Li, Shiwu
Li, Jiao
Liu, Jiewei
Wang, Junyang
Li, Xiaoyan
Huo, Yongxia
Li, Yifan
Liu, Yixing
Li, Ming
Xiao, Xiao
Luo, Xiong-Jian
Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title_full Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title_fullStr Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title_full_unstemmed Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title_short Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression
title_sort regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene tyw5 expression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014752/
https://www.ncbi.nlm.nih.gov/pubmed/34581804
http://dx.doi.org/10.1093/brain/awab357
work_keys_str_mv AT lishiwu regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT lijiao regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT liujiewei regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT wangjunyang regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT lixiaoyan regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT huoyongxia regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT liyifan regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT liuyixing regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT liming regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT xiaoxiao regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression
AT luoxiongjian regulatoryvariantsat2q331conferschizophreniariskbymodulatingdistalgenetyw5expression